September 25, 2016 5:38 PM ET


Company Overview of Prexa Pharmaceuticals, Inc.

Executive Profile

Charles M. Cohen Ph.D.

Co-Founder, Chairman of The Board and Chief Executive Officer , Prexa Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 8 different industries.

See Board Relationships


Dr. Charles M. Cohen, also known as Charlie, Ph.D., is a Co-Founder of Synthesis Capital. Dr. Cohen served as a Vice President of Biological Sciences at Xenon Pharmaceuticals Inc. At Synthesis Capital, Dr. Cohen focuses on investments in private companies in the biopharmaceutical, healthcare, life science venture capital, and medical technology industries since 2003. Dr. Cohen joined Advent's healthcare and life sciences venture capital team in mid-2003. He co-founded ...

Corporate Headquarters

184 High Street
Boston, Massachusetts 02110

United States

Phone: 617-780-1443
Fax: --

Board Members Memberships

Co-Founder, Chairman of the Board and Chairman of Supervisory Board
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
Co-Founder, Chairman of The Board and Chief Executive Officer


Harvard University
Post-Doctoral Training
University of Virginia
University at Buffalo
PhD 1976
NYU Elaine A. and Kenneth G. Langone Medical Center

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Prexa Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at